MedTech News
.................... by Andrew Celentano
Senphonix secures NSF grant for SleeveSense wearable development
The grant will assist Senphonix and the University of Arizona in their efforts to strengthen the device’s wireless components.
XCath secures FDA breakthrough designation for remote thrombectomy robot
With the FDA designate in hand, XCath will further the development of its system that is intended to broaden access to stroke treatment globally.
Nutromics’ drug monitoring patch secures FDA breakthrough designation
Breakthrough designation for Nutromics’ namesake patch applies to the wearable platform’s function in vancomycin drug monitoring.
Light-based scans can uncover hidden tissue damage in pelvic organ prolapse
Pelvic organ prolapse is a common but often overlooked condition that affects millions of women. It occurs when the tissues that support the pelvic organs weaken, allowing organs such as the bladder, uterus or rectum to shift from their normal position. Doctors can assess how severe the prolapse is, but existing tools do not provide much information about what’s happening inside the tissue itself.
First-in-human study attacks inoperable pancreatic tumors with laser light
UCI Health, the clinical enterprise of the University of California, Irvine, is conducting a first-in-human, Phase I clinical trial using laser light to target localized but inoperable pancreatic tumors to help patients become cancer-free.
New ‘smart’ nanoparticles help the immune system better attack tumors
Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body’s anticancer immune response.
Blood and gene tests predict Alzheimer’s symptoms three to six years ahead
Columbia University researchers have identified a way to help predict when people at high risk of developing Alzheimer’s are likely to develop their first symptoms, a finding that could help physicians decide when to prescribe preventive treatments currently in development.
IceCure Medical Receives Regulatory Approval to Market ProSense® in China
IceCure Medical Ltd. announced that it has received approval, as a Class III medical device, from China’s National Medical Products Administration (“NMPA”) for its ProSense® system and associated cryoprobes.